Silver Book Fact

According to the Pharmaceutical Research and Manufacturers of America, researchers are currently working on 646 medicines for cancer. All are either in clinical trials or under FDA review. They include 96 for lung cancer, 79 for breast cancer, 66 for colorectal cancer, and 79 for prostate cancer. Other medicines target brain, kidney, ovarian, pancreatic, skin, and other cancers. Companies are also working on medicines to improve quality of life for those with cancer.

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • According to the Pharmaceutical Research and Manufacturers of America, a medicine in development targets CA125, a surface protein, or antigen, that is released in excess quantities by some ovarian cancers.…  
  • Since the war on cancer was declared in 1971, our arsenal has tripled. New drugs accounted for around 50-60% of the increase in six-year cancer survival rates since 1975.…  
  • From 2007 to 2011, lung cancer incidence rates decreased by three percent each year in men and 2.2 percent each year in women.  
  • A one percent reduction in cancer-related deaths in the U.S. would be worth an estimated $500 billion to society from increased quality of life and increased productivity from longer lives.  
  • FDA Cancer Approvals for Aug 2014 to July 2015